[Characteristic features of bone disease in disseminated carcinomatosis of bone marrow].
Iguchi
Haruo
H
Clinical Research Institute, Shikoku Cancer Center.
Matsuhisa
Tetsuaki
T
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D019046:Bone Marrow Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy* / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D053245:RANK Ligand / Q000502:physiology; D013274:Stomach Neoplasms / Q000473:pathology*
D000925:Anticoagulants; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D053245:RANK Ligand